Substance use Current research indicates a link between GLP-1s and reduced incidence and recurrence of alcohol use disorder
UHCs 2026 commercial PA criteria for Wegovy require five elements: BMI of 30 or higher, or BMI 27 to 29.9 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, OSA, CVD), documentation of a structured weight management program for at least 6 months in the past 24 months, prescriber attestation that lifestyle changes alone have been inadequate, age 18 or older, and concurrent reduced-calorie diet and physical activity
More research to be conducted is still needed to verify the reliability of the results
Also report new neurologic symptoms, chest pain, or signs of bowel obstruction
Affordable Safe, quality treatment at an attainable price with or without insurance Convenient Easy refills & free shipping to your door
Form Healths physicians will have full discretion over who they prescribe the medications to, or if a weight loss drug is the right fit for a patient
